Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Chemours CoCC · Entity 4420 | SVP, GC & Corp. Secretary | May 05, 2022 | May 09, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Chemours Co
Report date May 05, 2022 · Filed May 09, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 51,125.1164 |
Last balance in matching sequence
After 2022-05-05 transaction · row 4
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
4 source rowsRow 1 · 2022-05-05 · Exercise / conversion · Acquired 83,044 · Balance 134,169.1164 F1: Includes directly owned shares, restricted stock units, and dividend equivalent units. Row 2 · 2022-05-05 · Sale · Disposed 83,044 · Balance 51,125.1164 F2: Shares were sold in multiple transactions at prices ranging from $39.68 to $40.47. F1: Includes directly owned shares, restricted stock units, and dividend equivalent units. Row 3 · 2022-05-05 · Exercise / conversion · Acquired 67,736 · Balance 118,861.1164 F1: Includes directly owned shares, restricted stock units, and dividend equivalent units. Row 4 · 2022-05-05 · Sale · Disposed 67,736 · Balance 51,125.1164 F2: Shares were sold in multiple transactions at prices ranging from $39.68 to $40.47. F1: Includes directly owned shares, restricted stock units, and dividend equivalent units. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.40 · Expires 2026-03-01 | Direct | 0 |
Reported balance
After 2022-05-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-05 · Exercise / conversion · Disposed 83,044 · Balance 0 F3: Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.43 · Expires 2030-03-02 | Direct | 33,868 |
Reported balance
After 2022-05-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-05 · Exercise / conversion · Disposed 67,736 · Balance 33,868 F4: Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021. |
| Common StockSEC Table I · non-derivative | IndirectBy GRAT | 91,992 |
Reported balance
Holding disclosure · report date 2022-05-05 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 91,992 |
Filing footnotes · ownership attribution and instrument terms
F1: Includes directly owned shares, restricted stock units, and dividend equivalent units.
F2: Shares were sold in multiple transactions at prices ranging from $39.68 to $40.47.
F3: Option award was granted on March 1, 2016 with vesting in three equal annual installments beginning March 1, 2017.
F4: Option award was granted on March 2, 2020 with vesting in three equal annual installments beginning March 2, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2017 Filed Oct 5, 2017 21:56 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 6,000 | $53.00 | $318,000.00 |
DisclosureSEC source: 0001627223-17-000055 · primary_doc.xml · nonDerivative · entry 2 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,448 F2 · price: Shares were sold in multiple transactions at prices ranging from $53.00 to $53.01. Read SEC document |
| October 03, 2017 Filed Oct 5, 2017 21:56 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 6,000 | $11.87 | $71,220.00 |
DisclosureSEC source: 0001627223-17-000055 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2017. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 08:12 UTC Amendment | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,337 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001627223-17-000052 · primary_doc.xml · derivative · entry 4 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,337 shares Expires 2019-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 08:12 UTC Amendment | Chemours Co CC · Entity 4420 | SaleCommon Stock | 13,337 | $48.48 | $646,577.76 |
DisclosureSEC source: 0001627223-17-000052 · primary_doc.xml · nonDerivative · entry 2 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,429 F3 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $48.18 to $48.60. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 08:12 UTC Amendment | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 13,337 | $12.96 | $172,847.52 |
DisclosureSEC source: 0001627223-17-000052 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The stock option exercise and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2017. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 07:30 UTC Amendment | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,337 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001627223-17-000051 · primary_doc.xml · derivative · entry 4 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,337 shares Expires 2019-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 07:30 UTC Amendment | Chemours Co CC · Entity 4420 | SaleCommon Stock | 13,337 | $48.48 | $646,577.76 |
DisclosureSEC source: 0001627223-17-000051 · primary_doc.xml · nonDerivative · entry 2 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,429 F2 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $48.18 to $48.60. F1 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 07:30 UTC Amendment | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 13,337 | $12.96 | $172,847.52 |
DisclosureSEC source: 0001627223-17-000051 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 06:50 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionStock Option (Right to Buy) · Derivative | 13,337 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001627223-17-000050 · primary_doc.xml · derivative · entry 4 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,337 shares Expires 2019-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 06:50 UTC | Chemours Co CC · Entity 4420 | SaleCommon Stock | 13,337 | $48.48 | $646,577.76 |
DisclosureSEC source: 0001627223-17-000050 · primary_doc.xml · nonDerivative · entry 2 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,429 F2 · price: Price reported is a weighted average. Shares were sold in multiple transactions at prices ranging from $48.18 to $48.60. F1 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 06:50 UTC | Chemours Co CC · Entity 4420 | Exercise / conversionCommon Stock | 13,337 | $12.96 | $172,847.52 |
DisclosureSEC source: 0001627223-17-000050 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| March 09, 2017 Filed Mar 10, 2017 20:31 UTC | Chemours Co CC · Entity 4420 | GrantStock Option (Right to Buy) · Derivative | 19,788 | $0.00 Strike: $34.72 | $0.00 |
DisclosureSEC source: 0001627223-17-000023 · primary_doc.xml · derivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,788 Underlying: Common Stock · 19,788 shares Expires 2027-02-28 F1 · derivative.exercise_date: The option vests in three equal annual installments beginning on March 1, 2018. Read SEC document |
| February 13, 2017 Filed Feb 15, 2017 21:05 UTC | Chemours Co CC · Entity 4420 | GrantCommon Stock | 30,596 | $0.00 | $0.00 |
DisclosureSEC source: 0001627223-17-000014 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,378 F1 · shares: Performance-based restricted stock units that vest on August 4, 2018. F2 · balance_after: Includes directly owned shares, unvested restricted stock units and dividend equivalent units. Read SEC document |
| February 05, 2017 Filed Feb 7, 2017 21:03 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 721 | $27.62 | $19,914.02 |
DisclosureSEC source: 0001627223-17-000006 · primary_doc.xml · nonDerivative · entry 2 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,781 F1 · shares: Shares withheld for tax obligations on vested restricted stock units (RSUs) and dividend equivalent units (DEUs). No shares were sold. F2 · balance_after: Includes directly owned shares, unvested RSUs and DEUs. Read SEC document |
| February 04, 2017 Filed Feb 7, 2017 21:03 UTC | Chemours Co CC · Entity 4420 | Tax withholdingCommon Stock | 493 | $27.62 | $13,616.66 |
DisclosureSEC source: 0001627223-17-000006 · primary_doc.xml · nonDerivative · entry 1 Shelton David C · CIK 0001645179 · SVP, GC & Corp. Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,502 F1 · shares: Shares withheld for tax obligations on vested restricted stock units (RSUs) and dividend equivalent units (DEUs). No shares were sold. F2 · balance_after: Includes directly owned shares, unvested RSUs and DEUs. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.